Trials / Recruiting
RecruitingNCT06040112
Effect of Atelocollagen Injection in Patients With Calcific Tendinitis
- Status
- Recruiting
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 46 (estimated)
- Sponsor
- Hyungsuk Kim · Academic / Other
- Sex
- All
- Age
- 20 Years – 69 Years
- Healthy volunteers
- Accepted
Summary
Assess the clinical outcomes using atelocollagen injection in patients with calcific tendinitis.
Detailed description
Suitable participants based on the selection/exclusion criteria are randomly assigned to either the case group or the control group. Consent is given right before the procedure. Case group (Atelocollagen injection group): Ultrasound-guided barbotage followed by lidocaine and atelocollagen injection. Control group (Lidocaine injection group): Ultrasound-guided barbotage followed by lidocaine injection." Clinical outcomes will be assessed with functional scores on 6 months after injection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Atelocollagen | Tendoregen (Atelocollagen) injection |
Timeline
- Start date
- 2023-12-06
- Primary completion
- 2024-12-01
- Completion
- 2025-06-01
- First posted
- 2023-09-15
- Last updated
- 2024-04-12
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06040112. Inclusion in this directory is not an endorsement.